Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty

(2020) Jeffrey I. Weitz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction

(2020) Claudia Hanni et al.   Blood Advances

Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation

(2018) Austin Hu et al.   SEMINARS IN NEPHROLOGY

The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials

(2017) Stanley T. Crooke et al.   Nucleic Acid Therapeutics

The atrial fibrillation conundrum in dialysis patients

(2016) An S. De Vriese et al.   AMERICAN HEART JOURNAL

Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events

(2016) Meir Preis et al.   BLOOD

Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides

(2015) Richard S. Geary et al.   ADVANCED DRUG DELIVERY REVIEWS

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

(2015) Harry R. Büller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

(2015) Kaitlyn Shaw et al.   THERAPEUTIC DRUG MONITORING

Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women

(2014) B. Siegerink et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Drug adherence in chronic kidney diseases and dialysis

(2014) M. Burnier et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Novel Hemostatic Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study

(2010) M. Fareed K. Suri et al.   CEREBROVASCULAR DISEASES

Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis

(2010) Ophira Salomon et al.   THROMBOSIS AND HAEMOSTASIS

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology

(2009) M. Cushman et al.   BLOOD

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

(2008) O. Salomon et al.   BLOOD

Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe

(2008) Rosie Z Yu et al.   CLINICAL PHARMACOKINETICS